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                               Abstract 
 
 
Introduction:   Patients with COPD presenting to the Emergency Unit with acute 
hypercapnic respiratory failure often require invasive mechanical ventilation and 
subsequent admission to the intensive care unit (ICU). These patients are at an 
increased risk of prolonged and complicated ventilation and often experience weaning 
difficulties. In addition, the impact of a previous episode of pulmonary tuberculosis 
that might have resulted in structural lung disease on the duration of mechanical 
ventilation in such patients has not previously been evaluated. 
 
Methods:  All patients with COPD admitted to the Respiratory ICU at Tygerberg 
academic hospital from the 01st January 2004 until 31st December 2007 requiring 
intubation and invasive mechanical ventilation for acute hypercapnic respiratory 
failure were included in the study. Patients were categorized into those ventilated for 
longer than 7 days (defined as prolonged mechanical ventilation - PMV) and those 
surviving 7 days after admission to the ICU and who were successfully weaned (non-
PMV). Early clinical and biochemical variables recorded within the first 24 hours 
after admission were evaluated and compared. The primary comparison was made on 
patients that survived for more than 7 days, comparing those ventilated for longer than 
7 days with those successfully weaned on or earlier than the 7th day. 
 
Results:  A total of 69 patients were evaluated; 45 in the non-PMV and 24 patients in 
the PMV group. Baseline demographic, clinical, biochemical and radiological data for 
the 2 groups obtained in the first 24 hours were compared. Statistically significant 
differences in the following early clinical variables were found on univariate analysis: 
the presence of chest pain (p < 0.05), neurological impairment on admission (p < 
0.05), the presence of shock (p<0.05  ) and the early use of inotropes( p<0.05  ), a 
high requirement for oxygen (FiO2; p=0.001), low serum albumin (p =0.05), low 
haemoglobin (p<0.01), the presence of a respiratory pathogen on blood culture 
(p<0.05) and a high APACHE II score(p= 0.04).A history of previous exposure to TB, 
the presence of cor pulmonale, ischaemic heart disease and structural lung disease (p 
= 0.07) were not statistically significant.  
 
Conclusion:  The early clinical features that predict the need for prolonged 
mechanical ventilatory support in patients with acute hypercapnic respiratory failure 
represents the severity of acute respiratory failure (FiO2), concurrent cardiac disease 
and /or circulatory failure (chest pain and/or shock with need for inotropes and 
possibly neurological impairment), sepsis (shock and positive blood culture) and 
severe concurrent disease (low serum albumin and /or haemoglobin and high 
APACHE II score). These may be of use in planning and in policy development for 
ICU services in the Western Cape and similar settings with restricted availability of 
ICU services.  
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Research question:  
 
 
 
    What are the risk factors associated with prolonged mechanical ventilation in patients 
with Chronic Obstructive Pulmonary Disease (COPD) requiring mechanical 
ventilation for acute hypercapnic respiratory failure?  
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     Introduction 
     
     The mortality of patients with Chronic Obstructive Pulmonary Disease (COPD) has 
increased steadily since the 1960’s (1, 2). The World Health Organization (WHO) 
estimates that 80 million people worldwide had moderate to severe COPD in 2005 
and that 3 million people died of the disease in that year .In addition, it further 
estimates that COPD will become the third leading cause of death by 2030. (3)  
 
      Patients with COPD presenting to the Emergency Department (ED) with acute 
hypercapnic respiratory failure often require invasive mechanical ventilation and 
subsequent admission to the Intensive care unit (ICU) (4, 5). They are at an increased 
risk of prolonged ventilation, complications and often experience weaning difficulties 
(5, 8,9,11,13,15). These problems result in an increased morbidity and mortality and 
place a considerable strain on health resources globally (6). 
 
     The early identification of predictors of prolonged mechanical ventilation (PMV) 
could assist clinicians in the management of these patients. Recognition of these 
might both enable physicians to correct variables that could change the course of the 
ICU stay, and assist in the efficient planning of health resources and ICU bed 
requirements. It might also inform policy and prevent admission of patients with very 
poor prognoses. 
 
     COPD in the Western Cape is known to be different to that in most developed 
countries.  The direct applicability of risk factors derived from overseas studies to our 
unique patient pool is thus questionable. There is a high incidence of both HIV and 
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Tuberculosis as well as adult malnutrition, essential hypertension, diabetes mellitus, 
cardiac failure and ischemic heart disease. (7, 8). Patients with COPD thus often have 
multiple co-morbidities and may pose diagnostic dilemmas to attending clinicians. 
The impact of these factors on the mechanical ventilation of patients with COPD has 
not previously been evaluated in South Africa. 
 
The aim of the current study is to identify early clinical variables predictive of 
prolonged mechanical ventilation (PMV) and weaning difficulties in patients with 
COPD admitted with acute hypercapnic respiratory failure 
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 Methods 
 
5.1 Study Design: A retrospective cohort study . 
 
5.2 Study Population:   
 
     All patients with COPD admitted to the Respiratory ICU at Tygerberg academic 
hospital from the 01st January 2004 until 31st December 2007 with the problem of 
acute hypercapnic respiratory failure was included in the study. Since patients who 
died within the first 7 days of admission could not be eligible for prolonged 
ventilation only those that survived for 7 days were included in the study. Patients 
requiring intubation and invasive mechanical ventilation were evaluated and 
categorized into those ventilated for longer than 7 days (defined as prolonged 
mechanical ventilation) and those who were successfully weaned in 7 days or less 
(non-PMV group). Clinical variables measured and recorded within 24 hours of 
admission were evaluated and compared. The impact of  co-morbidities including a 
history of pulmonary tuberculosis, was also assessed. 
 
Where available the diagnosis of COPD was made on the basis of spirometry; a 
previous lung function test performed within the last 3 years or once the patient had 
recovered from the current ICU admission. In the absence of documented airflow 
obstruction, the diagnosis of COPD was made by the attending consultant clinician 
who was registered as a pulmonologist or critical care specialist with the Health 
Professions Council of South Africa. In such cases, the diagnosis of COPD was based 
on the PALSA (Practical Approach to Lung Health in South Africa) diagnostic 
Student  09/5/19 3:17 PM
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algorithm (18). This validated algorithm which is used in resource poor settings to 
diagnose COPD (where pulmonary function testing is not available) employs the 
following questions: 
• Whether symptoms suggestive of COPD started later in life (usually after the 
age of 35 years) 
• Whether symptoms worsened slowly over a period of time 
• Whether there was a long history of daily or frequent cough and sputum 
production  
• Whether patients were short of breath for most of the day, rather than at night 
or during the early hours of the morning ( before their acute deterioration) 
• Whether there was history of heavy smoking e.g. more than 20 cigarettes/day 
for 15 years or more. 
 
The decision to intubate patients for acute hypercapnic respiratory failure was made 
by the attending clinician. The general guidelines used by the clinicians were (17): 
• apnoea or respiratory pauses with loss of consciousness or gasping for air or 
imminent respiratory arrest, 
• acute exacerbation of COPD with hypercapnic respiratory failure, tachypnea 
or severe dyspnoea plus at least one of the following  
a. altered mental status or persistent uncooperativeness; 
b. acute cardiovascular instability;  
c. inability to protect the lower airway or copious secretions;  
d. patients who could not tolerate non-invasive ventilation (NIV) or the 
development of progressive respiratory acidosis despite intensive 
initial therapy 
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An “exacerbation” of COPD was defined as the presence of at least 2 of the 3 
respiratory symptoms of dyspnoea, cough or purulent sputum production of sufficient 
severity to require admission to hospital (at the admitting doctor’s discretion)(13). 
Acute hypercapnic respiratory failure was defined as a PaCO2 ≥ 6.6 kPA (50 mm Hg) 
and pH≤7.30 as measured by the pre-intubation arterial blood gas (ABG) analysis. 
 Patients were excluded from the analysis if any of the following were present: 
• Unknown duration of mechanical ventilation prior to admission to the ICU 
• Intubated for reasons not related to acute hypercapnic respiratory failure 
• Patient died before 7 days  post-admission  
• Insufficient clinical data ( i.e. if in the judgement of the researcher there 
was insufficient clinical and/or laboratory data in the medical records. 
Information relating to details of the current presentation, relevant 
investigations such as arterial blood gas analysis, chest radiographs, ECGs 
and a previous history relating to COPD were considered essential before 
patients were accepted onto the study) 
 
The decision to perform a tracheostomy was made by the attending clinicians in the 
ICU. A standardised protocol to perform a tracheostomy was not followed. Instead, 
patients had a tracheostomy if the attending clinician anticipated prolonged and 
complicated ventilation. Patients were only weaned once they had recovered 
sufficiently from the initial insult which caused their acute deterioration. The weaning 
process involved a gradual reduction in the synchronised intermittent and pressure 
support ventilation. Patients were generally kept on small amounts of PEEP during 
the weaning phase (2 cm water). Patients were placed on pressure support ventilation 
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once they were breathing spontaneously and did not require any additional 
synchronized breaths from the ventilator. Those who failed their initial weaning and 
who required up to three Spontaneous Breathing Trials(SBT) or as long as 7 days 
from the first SBT to achieve successful weaning were defined as having a 
“prolonged wean”. 
 
Patients were only extubated when they tolerated a minimum of 30-120 minutes of 
minimal ventilatory support (intermittent ventilation = 0, pressure-support ventilation 
< 10cm H2O), had demonstrated a significant improvement in their level of 
consciousness once all sedation had been stopped and had demonstrated good 
respiratory muscle strength. Patients who required re-intubation or who died within 72 
hours of extubation were classified as having failed extubation. 
 
Patients were routinely administered nebulised bronchodilators (using salbutamol and 
ipratropium bromide) before intubation, whilst being ventilated and in the post-
extubation period. They were also routinely administered subcutaneous heparin 
(unless a bleeding diathesis existed) and sucralfate through a feeding tube. Patients 
who were clinically assessed to have an exacerbation of COPD due to sepsis (viral or 
bacterial), also received appropriate antibiotics in keeping with South African 
Thoracic Society guidelines.[19]. With the exception of patients admitted to the ICU 
for peri-operative bronchoconstriction, all other patients received systemic 
corticosteroids. At the discretion of the attending clinician, select cases received 
intravenous theophylline for ongoing bronchoconstriction despite optimal therapy 
listed above. Whilst on full ventilation, patients were sedated with either midazolam 
or morphine to attain a Ramsay sedation score between 3 and 4. As per ICU policy, 
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sedation was interrupted for 2 hours in the morning from 06H00-08H00.The sedation 
was also weaned as patients improved, airway pressures fell and need for ventilatory 
support reduced. 
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Statistical analysis 
      A health statistician, using the Statistica version 8 programme, performed the 
analysis. Values in the PMV and non-PMV groups were compared by univariate 
analysis to identify potential prognostic variables. Multiple logistic regression 
analysis was performed to confirm their significance. Between group differences in 
categoric variables assessed using the Chi-squared squared test and continuous 
variables by the student t-tests. Continuous variables are presented as mean + SD (or 
median with range in a non-normal distribution).Categorical variables are presented 
as a number. 
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Results 
During the 4-year period of our study, 77 patients with COPD were admitted for acute 
hypercapnic respiratory failure requiring mechanical ventilation. Five patients died 
within 7 days from admission and were excluded from the study. A further 3 patients 
were excluded due to insufficient clinical information in their medical records. We 
were thus left with a sample of 69 patients which were evaluated. 
 
The mean age in the non-PMV and PMV group was 58( +4) and 55 ( + 4) years 
respectively (table 1). There was a male predominance in the non-PMV group (29 
males vs. 16 females) but significantly more females in the PMV group ( 15 females 
vs. 9 males ) (table 2). A high proportion of current smoking was noted in both groups 
(59 of 69 patients (85%)), but there were no significant difference in the smoking 
pack year history between the 2 groups. The majority of patients in both groups who 
presented with acute hypercapnic respiratory failure had an established diagnosis of 
COPD at the time of presentation. In the non-PMV group, this diagnosis was made at 
a primary care facility (77%). In 42% of patients in the PMV group, their usual 
outpatient follow-up was at a secondary hospital. Pulmonary function testing (either 
prior to or upon discharge) was only performed in one third of the patients (n = 24). 
The FEV1 expressed as percent predicted was 49 % and 38% in the non-PMV and  
PMV group respectively indicating that the majority of patients in the study were in 
stage III according to the Global Initiative for Chronic Obstructive Lung Disease 
rating of severity. 
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Table 1 
 
Baseline Demographic characteristics  
 
  non-PMV PMV  
  
n = 
45 SD n=24 SD 
† p-
value 
Age    58 + 4 55 + 4 0.32 
Sex Male 29   9     
  Female 16   15     
Smoking Current 40   19     
  Previous 4   3     
  Never 2   1     
  pack years 30 +6 33 +7 0.41 
Known COPD*   44   23     
FEV1 (% predicted) (n)*** (n=23) 49 +14 38 +22 0.54 
FEV1/FVC ratio        (n)*** (n=23) 0.55 +0.08 0.44 +0.14 0.08 
Use of Inhaled Steroids 
(n)*** n = 12 11   1      <0.05 
Follow-up primary care facility 35   14     
  Secondary care facility 4   10     
  Tertiary care facility 6   0     
Functional status**  Mean 2.18 +0.3 2.43 +0.25 0.57 
EU presentation to ICU admission (hours) 
 
42 +24 53 +30 0.01 
 
 
† Mann-Whitney analysis 
***  FEV1 and FEV1/FVC ratio: n = 23; PMV = 6 patients, non-PMV = 17 
*Patients established with the diagnosis of COPD prior to hospitalization 
**Functional status -    Grade 1- independent 
- Grade 2- Restricted but leaves house 
- Grade 3- Housebound but ambulant and able to perform self care 
- Grade 4- Bed/chair bound, unable to perform self-care 
 
EU = Emergency Unit, ICU = Intensive care unit 
 
 
 
 
 
 
 
 
 
 
 PMV non-PMV Total 
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Table 2  
 
Chi-Square table reflecting the gender distribution in the PMV and non-PMV 
groups respectively  
 
 
The majority of patients in both groups had a grade 2-3 functional status with no 
significant difference between the 2 groups. Delay in the transfer from the Emergency 
unit to the ICU was associated with prolonged ventilation. A further 11 hour delay in 
the transfer from the EU to the ICU placed the patient at a statistically significant risk 
of prolonged mechanical ventilation (p=0.01). 
 
 
An expected finding was that an exacerbation of COPD due to pneumonia was the 
predominant cause of acute deterioration requiring ventilatory support in both groups. 
(Figure 1).This was however not a statistically significant (p=0.42) predictor of PMV. 
The diagnosis of pneumonia was made if the admitting chest radiograph demonstrated 
pulmonary infiltrates compatible with pneumonia in a patient with a short history of 
cough and purulent sputum. However, neither the admitting clinician nor the 
attending radiologist was blinded when interpreting the chest radiograph. This raises 
the possibility that patients could have been overdiagnosed with pneumonia thereby 
limiting the assessment of pneumonia as a predictive factor for PMV. There were only 
2 cases of active pulmonary tuberculosis precipitating or concurrent with an acute 
exacerbation of COPD and both were in the non-PMV group. In addition, there were 
no patients requiring PMV for acute exacerbations caused by a pneumothorax, acute 
heart failure, acute coronary syndrome or a surgical non-respiratory intervention. 
 
 
 
Male  9                   (37%)  29                  (64%) 38 
Female 15                  (63%) 16                  (36%) 31 
Total 24 45  
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Figure 1: Causes and co-morbid conditions in patients with COPD requiring 
mechanical ventilation for acute respiratory failure.  Number of patients 
requiring prolonged mechanical ventilation defined as more than 7 days is shown 
in white, and those weaned in 7days or less, in blue. 
 
 
None of several medical co-morbidities nor structural lung disease predicted PMV 
(Table 3). An important observation was the high frequency (21.7%) of previously 
treated pulmonary tuberculosis in the study cohort; 11 patients (comprising 24% of 
the group) in the non-PMV and 4 patients(16.7%)in the PMV group respectively. The 
impact of being HIV positive on the duration of mechanical ventilation could not be 
evaluated in this cohort due to the low frequency of HIV testing during the study 
period (HIV status unknown in 62% of patients). A surprise finding was that cor 
pulmonale and structural lung disease did not seem to predict prolonged mechanical 
ventilation in our study cohort.  
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Table 3:  
 
Comparison of co-morbidities in COPD patients requiring prolonged mechanical 
ventilation for acute respiratory failure and those weaned within 7 days or less. 
 
  
non-
PMV   PMV   p-value 
  n = 45 Range n = 24 Range   
Charlson Co-morbidity 
score*   3.42 
(2.75-
4.09) 3.61 
(2.78-
4.45) 0.94 
PTB Previous 11   4   0.65 
  Current 2   0   NS 
HIV  positive 1   1   NS 
  negative 15   10   NS 
  unknown 30   13   NS 
Hepatitis/Cirrhosis   1   4     
Cor Pulmonale    20   8   0.37 
Non-Cor pulmonale   2   2   NS 
Chronic Renal Failure   1   3   NS 
Diabetes Mellitus   5   4   0.29 
Ischaemic Heart disease   9   3   0.51 
Active Malignancy   6   0   NS 
Structural Lung Disease**   18   4   0.07 
 
* Charlson Co-morbidity score predicts the 1 year mortality for patients with multiple 
co-morbid conditions such as heart disease, stroke or malignancy (a total of 22 
conditions). Each condition is assigned with a score (1, 2, 3 or) 6 depending on the 
risk of dying associated with this condition. The scores are then summed up and given 
a total score which predicts mortality. 
** The presence of irreversible fibrotic changes on a chest radiograph which might be 
associated with volume loss. 
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The clinical parameters for the 2 groups (Table 4) yielded a few interesting 
observations. The clinical presentation of chest pain was a statistically significant risk 
factor for prolonged ventilation (p <0.05) with 67% of patients in the PMV group 
having experienced this symptom. However, coronary ischemia on the 
electrocardiogram was only noted in 6 patients (25%) in the PMV group suggesting 
an alternative aetiological explanation in most. The early occurrence of shock 
requiring the use of inotropes in the Emergency Unit or ICU was a statistically 
significant risk factor for prolonged mechanical ventilation. Not surprisingly, these 
patients were initially hypotensive with reduced cerebral perfusion and a depressed 
level of consciousness. The associated neurological impairment was thus also found 
to be a statistically significant risk factor. Patients who presented with severe 
hypoxemia requiring a higher FiO2 were at risk of prolonged mechanical ventilation 
(p<0.05). However, the level of respiratory acidosis and the degree of carbon dioxide 
retention did not predict prolonged ventilatory requirements.  
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Table 4 
 
Comparison of clinical data obtained within 24 hours of admission to the 
Emergency Unit or ICU in COPD patients requiring prolonged mechanical 
ventilation for acute respiratory failure and those weaned in 7 days or less. 
 
    
non-
PMV    PMV   p-value 
    n=45 Range n=24 Range   
Symptoms Cough 26   18   0.2 
  Expectoration 18   15   0.12 
 Chest pain 9   16   
                
       <0.05 
  Neurological impairment 29   21   0.03 
Shock   2   8   
            
       <0.05 
Use of Inotropes within 24 hours of admission 2   8   
          
       <0.05 
Arterial Blood 
Gas FiO2 48.1 42-54.3 58.8 
(48 - 
69.5) 
          
       <0.05 
  pH 7.19 
7.13-
7.25 7.16 
7.07-
7.25 0.99 
  PCO2 9.9 
8.5-
11.4 10.3 8.5-12.1 0.79 
  PO2 15.6 12.2-19 14.1 7.8-20.4 0.13 
  Total CO2 26.8 
23.5-
30.2 30.3 
26.1-
34.5 0.27 
  Standard bicarbonate 23.7 
20.2-
27.2 27.5 
24.5-
30.5 0.16 
ECG Right ventricular strain 19   7   0.32 
  Coronary Ischemia 13   6   0.67 
Chest 
Radiograph 
Hyperinflation 
45   24   
             
           NS 
  
Pulmonary infiltrates 
compatible with pneumonia 18   14   0.09 
  
Pulmonary infiltrates (other 
than pneumonia) 8   4   1 
  Pneumothorax 5   2   0.72 
  Structural lung disease 8   4   0.07 
Albumin  g/L 27 23-31 24 19-29 0.05 
Haemoglobin  g/dl 11.6 
10.2-
13.1 8.6 6.6-10.6 0.01 
Creatinine  umol/L 103 84-122 135 98-171 0.13 
ALT  mmol/L 66 16-116 120 25-256 0.07 
CRP   67 33-100 102 54-151 0.2 
White Blood 
cells   X10 9 13.5 
11.6-
15.5 16.6 
11.9-
21.4 0.36 
Lactate   2.05 
1.48-
2.62 1.85 
1.38-
2.32 0.97 
Blood Culture positive for respiratory 
pathogen 4   15   
          
       <0.05 
APACHE II   15 12-17.5 19 16-23 0.04 
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The presence of a pulmonary infiltrates suggestive of pneumonia on the admission 
chest radiograph was almost statistically significant as a risk factor for prolonged 
ventilation, but a syndromic diagnosis was not (p-values of 0.09 vs. 0.42). However, 
confirmation of pneumonia by the isolation of a respiratory pathogen in a standard 
blood culture was significant (p <0.05). The presence of low serum albumin and/or 
haemoglobin was further statistically significant risk factors for PMV.  
 
An important observation was the presence of low haemoglobin values in both groups 
(especially in the PMV group). The reason for this observation is not clear but a 
possible explanation may be an undiagnosed occult malignancy (of possible 
gastrointestinal origin). Unfortunately, these patients were not specifically 
investigated for their anaemia and our retrospective study design prevents immediate 
action being taken.                                                                                              
 
Table 5 summarises the associations between ventilatory patterns and risk of PMV. 
The duration from initial presentation to intubation was not predictive of PMV. 
However, as expected, mechanical ventilation with a high level of pressure support 
was predictive of PMV (<0.05). Interestingly, a failed extubation was not predictive 
of a prolonged mechanical ventilation (p=0.89). 
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Table 5: Comparison of times to intubation and admission to the ICU, and 
complications and outcomes of mechanical ventilation in COPD patients 
requiring prolonged mechanical ventilation for acute respiratory failure and 
those weaned in 7 days or less. 
 
  
non-
PMV   PMV    p-value 
   n = 45 Range 
n = 
24 Range   
Presentation to intubation                  
(Hrs)   22 
3.6 - 
41.4 20 0 - 44 0.7 
EU presentation to ICU        
  admission(Hrs) 
  42 
22.4-
63.4 53 
14.6-
92.6 0.01 
Complications of MV VAP 3   15   
       
<0.05 
  
Prolonged 
wean 8   22   
       
<0.05 
  
Failed 
extubation 9   5   0.89 
  Tracheotomised 0   9   
       
<0.05 
 
 
 
The statistically significant prognostic variables are summarised in table 6. 
 
Table 6 : Summary of variables associated with prolonged mechanical 
ventilation in COPD patients requiring mechanical ventilation for acute 
respiratory failure. 
 
UnivariateAnalysis     
ANOVA Spearman 
Spearman 
p-value 
      
FEV1/FVC Ratio -0.42 0.08 
Blood Albumin -0.27 0.05 
Creatinine  0.27 0.08 
CRP 0.29 0.03 
Inspired O2%(FiO2) 0.43 <0.01 
Haemoglobin -0.37 <0.01 
APACHE II score > 19 0.35 <0.01 
Time from EU presentation to ICU admission (H) 0.34 0.01 
      
Chi-squared test p-value   
Use of Inhaled Steroids <0.05   
Presentation with chest pain <0.05   
Presentation with neurological impairment <0.05   
Shock  <0.05   
Use of Inotropes <0.05   
Respiratory pathogen isolated from blood culture <0.05   
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Multiple logistic regression analysis was performed including variables found to be 
significant on univariate analysis (table 7). When these were corrected for possible 
confounders within the model, only an elevated creatinine and isolation of a 
respiratory pathogen were found to be significant.  
 
 
 
Table 7: Logistic regression analysis of predictors of the need for prolonged 
mechanical ventilation in COPD patients requiring ventilatory support for acute 
respiratory failure. 
 
Logistic regression analysis p-value odds ratio 
Creatinine  0.03 1.01-48.7 
Respiratory pathogen on Blood culture 0.01 1.9-20.8 
FiO2  0.35   
Haemoglobin 0.87   
Neurological impairment  0.30   
Sex 0.14   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
 28 
Discussion 
This is the first South African study to evaluate risk factors associated with prolonged 
mechanical ventilation in patients with acute hypercapnic respiratory failure 
associated with COPD. We have demonstrated how a few practical clinical variables 
may predict those at risk of prolonged mechanical ventilation and a protracted ICU 
stay. This is of particular relevance in the Western Cape where a relatively small 
number of ICU beds serve a large proportion of the population and the pressure on 
beds is extreme. The early identification of risk factors will identify those at risk of a 
prolonged stay that place a greater burden upon health resources. In resource-limited 
settings, this may enable clinicians to prioritize patients for ICU admission in cases 
where there are multiple requests for a single bed. In this regard, the finding that a 
delayed admission to the ICU (a greater interval between presentation to hospital and 
ICU admission) during which patients may or may not be placed on mechanical 
ventilation is associated with PMV, is of practical importance and in keeping with the 
general observation in critical care medicine that the first 24 hours are critical and 
delay in initiating full critical care measures is associated with a worse prognosis. 
Holding patients with acute hypercapnic respiratory failure in Emergency Units while 
waiting for an ICU bed is associated with additional morbidity and increased financial 
cost to the health system (although the latter was not studied in this project). This fact 
needs to be emphasized and communicated to health care administrators and planners.  
 
An additional feature of delayed transfer is the relative lack of skills and personnel in 
the Emergency Unit for managing complex resuscitation and respiratory failure. In 
addition to medical and nursing staff shortages, there is a lack of expertise and 
support for use of complex equipment used for ventilating patients with respiratory 
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failure with an increased risk of use of excessive pressure leading to barotrauma, poor 
management of fluid balance and delays in initiating appropriate antibiotics. These are 
some of the several problems associated with delays in admitting patients to the ICU. 
 
Our study confirms the findings of several earlier studies. Liu et al (11) showed that 
an APACHE II > 20, the presence of shock, non-respiratory organ failure 
(predominantly cardiac and renal failure), refractory acidosis and age>65 years were 
found to be predictive of prolonged mechanical ventilation. In our study, APACHE II 
>19, shock and non-respiratory organ failure were also predictive of prolonged 
mechanical ventilation. However, since acute hypercapnic respiratory failure was an 
entry criterion for our study, acidosis was a feature in both groups and was not more 
severe in the PMV group. However, the greater refractoriness of the hypoxemia in the 
PMV group is suggested by the higher mean FiO2 in this group (59% versus 48% in 
the non-PMV and PMV groups respectively (p<0.05)). 
 
Gursel (13) demonstrated that a ventilator-associated pneumonia and sepsis was 
predictive of mechanical ventilation longer than 7 days. This was also demonstrated 
in our study. However, we showed that APACHE II and albumin were also predictive 
of a prolonged stay after 7 days whereas these two variables were predictive only for 
a stay longer than 21 days in Gursel’s study. As our patients were only followed up 
for 7 days, it is possible, that these 2 variables may also be predictive for a stay longer 
than 21 days. 
 
In keeping with a study by Moran et al (10), we also showed that the need for a 
tracheostomy was predictive of PMV. However, the longer a patient was ventilated 
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and subsequently stayed in the ICU, the greater the need became for a tracheostomy. 
A predictive relationship can therefore not be claimed.. A standardised protocol was 
not followed for the placement of the tracheostomy tube at a designated time after 
admission. The decision to perform a tracheostomy was made if the attending 
clinician anticipated a prolonged and complicated ventilation in view of the patient’s 
clinical status.  
 
Figure 2. Complications and outcome in 69 COPD patients requiring mechanical 
ventilation for acute respiratory failure. VAP = ventilator-associated pneumonia, 
prolonged wean defined as patients who fail initial weaning and require up to 
three Spontaneous Breathing Trials(SBT) or as long as 7 days from the first SBT 
to achieve successful weaning failed extubation defined as one or more attempt to 
remove an endobronchial tube that necessitated replacement of the tube or 
tracheostomy 
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In contrast to all previous studies on this topic, we also demonstrated that our patients 
were significantly younger (mean age = 55 years in the PMV group; SD + 4 years); 
possibly indicating the relatively earlier age of onset of COPD in Cape Town. Despite 
our patients being 10-15 years younger than those listed in the studies above, they had 
similar pulmonary function tests (in those in whom it was available) and were also 
categorised as severe COPD ( stage III GOLD).  
 
Our study also aimed to investigate the significant co-morbidities seen in patients 
presenting with a severe exacerbation of COPD requiring mechanical ventilation. We 
are the first to investigate the relationship between pulmonary tuberculosis and the 
duration of mechanical ventilation in patients with COPD. Our results suggest that 
previous pulmonary tuberculosis is not associated with PMV. The prevalence of 
previous pulmonary TB in our study was 21.7%. This is comparable to the overall 
14.5% prevalence (19.25% male, 11.9% female) of previous TB seen in the Cape 
Town cluster of the BOLD study (22). The slight difference could be explained by the 
significantly larger sample size used in the BOLD study (n=896). Interestingly, the 
patient cluster selected from Cape Town in the BOLD study were from 2 areas 
(Ravensmead and Uitsig) which are serviced by Tygerberg hospital. A second 
important observation in this study is that COPD patients who were ventilated for 
acute respiratory failure had a very strong smoking history with 95 % having a history 
of more than 30 pack years. Once again, this finding was similar to that in the BOLD 
study where 83% of men and 59% of women gave a history smoking at some stage in 
their lives. An unexpected finding was that the presence of cor pulmonale, ischemic 
heart disease and structural lung disease did not predict a PMV.  This is particularly 
significant as the presence of these variables in the past were used to screen patients at 
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risk for PMV and the allocation of ICU beds. As most patients did not receive an 
echocardiogram or a definitive test to evaluate their coronary arteries (e.g. coronary 
angiogram), we cannot reliably confirm or exclude the diagnosis of cor pulmonale or 
ischaemic heart disease in this patient group.  Whether the  presence of these variables 
conferred an increased mortality in the short to medium term is uncertain. 
 
It makes sense that patients who are critically ill at initial presentation are at the 
highest risk for PMV. These patients often had severe hypoxemia and required a high 
FiO2 to compensate for a large alveolar-arterial gradient (A-A gradient). In addition 
to their profound hypoxemia, they often required aggressive fluid resuscitation and 
inotropic support for septic shock. They were thus at a higher risk of acute renal 
failure secondary to acute tubular necrosis. From a biochemical point of view, they 
often had significantly elevated inflammatory markers (white cell count and highly 
sensitive C-reactive protein) and were more likely to have positive blood cultures.  
The activated state of their inflammatory system often manifested with a low albumin 
and anaemia. It is thus readily apparent why the variables listed in table 5 were shown 
to be statistically significant for predicting PMV in these patients. 
 
The finding that the presenting complaint of chest pain is an independent prognostic 
factor for PMV is somewhat surprising. As mentioned, 16 patients in the PMV group 
presented with chest pain. Of these patients, only 6 had evidence of coronary ischemia 
on their admitting ECG. Unfortunately, cardiac enzymes were not routinely requested  
and the absence of echocardiography makes it difficult to exclude pulmonary 
hypertension as a cause of the chest pain. Also,the possibility of acute pulmonary 
embolus needs to be considered as patients with COPD are at increased risk of 
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thromboembolism. Other likely causes are pleurisy and rib fractures in osteopenic 
patients. The causes and prognostic value of chest pain in this patient cohort are thus 
uncertain. Due to the retrospective nature of this study, it was not possible to 
influence the management in these patients and thus other causes of chest pain were 
not evaluated.  
 
The limitations of our study are follows: 
1. The relatively small patient numbers 
2. The selection bias resulting from the exclusion of patients who did not survive 
for 7 days post-admission. However, only 5 patients were excluded on this 
basis, which is unlikely to have significantly affected the statistical 
significance of the variables evaluated. 
3. The retrospective study design 
4. The fact that only 34% of patients had pulmonary function testing and 
documented airflow obstruction. 
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In Conclusion 
We have identified early clinical predictors in patients with COPD who presented 
with acute hypercapnic respiratory failure in an area endemic for tuberculosis. These 
variables may be of clinical value in assisting clinicians in the prioritization of 
admissions to the ICU in situations where there is great demand and insufficient ICU 
beds   
 
The importance of early admission of these patients to an ICU is confirmed, 
especially when multiple predictors of prolonged ventilation are present (for example, 
shocked requiring a high FiO2 and inotropes, those with anaemia and/or a low serum 
albumin, and those with blood-culture positive pneumonia). The importance of 
current smoking and the role of pulmonary tuberculosis as contributory causes as well 
as the relatively early age onset of severe COPD associated with respiratory failure 
deserves special study in this region. 
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List of Addenda 
 
Addendum 1 : Data Collection Sheet 
 
 1 Patient Identifier number:         
Date admitted (ddmmyy)   
Yes= Y                      
No=N Date discharged (ddmmyy)   
  Variable  Variable sub analysis   
  Age (years) Actual age   
  Gender Sex (M=1/F=2)   
  Smoking History Smoking History (C/P/N/U)   
  Pack Years   
  
Known COPD (including Chronic 
Bronchitis and emphysema) 
    
  
Usual Follow-up care provider 
(GP=G, PC=P, SC=S, T, V) 
Follow-up   
  
Functional status prior to 
hospitalization/deterioration 
Status (1, 2, 3, 4)   
  Use of Inhaled Steroids Seroids (Y , N)   
  Compliance (Y, N)   
  
Oral steroid usage Long term use of oral 
steroids (>30days) 
  
    
Number of short    ( < 14 
days) courses of oral 
prednisone over last year  
  
  Daily use of B2 agonists     
  Daily use of  Ipratropium bromide     
  Daily use of  oral theophylline     
  
Daily use of  long-acting B2-
agonist 
    
  Daily use of B-Blockers     
  Daily use of NSAIDS/Aspirin     
  Domiciliary Home Oxygen (Y, N)   
  Charlson Comobidity Score* Score   
  Charslon morbidity index Index   
  History of Pulmonary Tuberculosis Currently on treatment   
  Previously treated   
  Never   
    Hs of non-compliance   
    Number of PTB episodes   
  HIV status HIV (P, N, U)   
  CD4 count if known   
  On Anti-Retroviral therapy   
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 2 Cirrhosis     
  Immunosuppressed     
  Cor Pulmonale (clinical or ECG)     
  Non-cor pulmonale      
  Chronic Renal Failure     
  Diabetes Mellitus     
  History of Myocardial Infarction     
  Ischemic heart disease     
  Active Malignancy     
  
Previous ABG prior to current 
presentation 
Type (1, 2) or Normal (n)   
  FEV1 ( % predicted) in last 5 years FEV1%   
  FEV1 (ml) FEV1   
  FEV1/FVC Ratio Actual ratio   
  
Previous Hospital admission for 
COPD exacerbation in last year 
(Y, N)   
  
  Number of Hospitalizations 
in last year 
  
  
Number of Emergency unit visits 
for COPD exacerbation in 
preceeding  year 
    
  
Number of unscheduled medical 
visits to day hospital/GP in 
preceeding year 
    
  Previous Intubation for COPD Yes/No   
  
  Number of previous 
intubations 
  
  
Occupational exposure to gas, 
fumes or dust 
yes/no   
  Previous Chest surgery     
  Other known Lung Disease     
  Known Drug Allergies     
  Cause of COPD  Non-infective exacerbation   
  Exacerbation Pneumonia   
    Pulmonary Embolus   
    Pneumothorax   
    Heart Failure   
    Ischemic Heart Disease   
    Post-Operative period   
  
  Active Pulmonary 
Tuberculosis   
    Other   
  Increased recent Dyspnoea   
    Cough   
    Expectoration   
    Chest pain   
    Sputum purulence   
  Signs of severity Cyanosis   
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 3   Neurological impairment   
    Lower limb oedema   
    unable to complete sentences   
    Use of accessory muscles   
  Heart rate (beats/min)     
  Respiratory Rate (breaths/min)     
  Arterial Blood Pressure (mm Hg)     
  Shock      
  Urine output / 24 hours (ml)     
  Treatment given  B2 agonists   
    Anti cholinergic agents   
    Inhaled steroids   
    Systemic steroids   
    Oxygen therapy   
    Antibiotics   
    Inotropes   
     Theophylline   
  Arterial Blood Gas: Ph   
  PCO2 (Kpa)   
  PO2 (KPA)   
  Total HCO3 (mmol)   
    Standard HCO3 (mmol)   
    BE   
  ECG  Right ventricular Strain   
  
Evidence of coronary 
Ischemia 
  
  Chest Radiograph Hyperinflation   
  
Pulmonary infiltrates 
compatible with pneumonia 
  
  
Pulmonary infiltrates (other 
than pneumonia) 
  
  Pneumothorax   
  Structural lung disease   
  Blood Albumin(g/l)     
  Haemoglobin     
  Haematocrit     
  Creatinine (umol/L)     
  ALT     
  CRP     
  
White cell count                (X 10 to 
power 9) 
    
  Heart rate (beats/min)     
  Respiratory Rate (breaths/min)     
  Arterial Blood Pressure (mm Hg)     
  Shock      
  Urine output / 24 hours (ml)     
  Treatment given  B2 agonists   
    Anti cholinergic agents   
    Inhaled steroids   
    Systemic steroids   
    Oxygen therapy   
    Antibiotics   
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4   Inotropes   
    Theophylline   
  Arterial Blood Gas: Inspired O2%   
  Ph   
  PCO2 (Kpa)   
  PO2 (KPA)   
  Total HCO3 (mmol)   
    Standard HCO3 (mmol)   
    BE   
  ECG  Right ventricular Strain   
  
Evidence of coronary 
Ischemia 
  
  Chest Radiograph Hyperinflation   
  
Pulmonary infiltrates 
compatible with pneumonia 
  
  
Pulmonary infiltrates (other 
than pneumonia) 
  
  Pneumothorax   
  Structural lung disease   
  Blood Albumin(g/l)     
  Haemoglobin     
  Haematocrit     
  Creatinine (umol/L)     
  ALT     
  CRP (mg/L)     
  
White cell count                (X 10 to 
power 9) 
    
  Lactate     
  Blood culture Positive (p) or negative (n)   
    Respiratory pathogen   
    non-respiratory pathogen   
  
Non-Invasive Ventilation Time on NIV before 
Intubation(hours) 
  
  Time from presentation to intubation Time (hrs)   
  
Time from EU presentation to ICU 
admission 
Time(hours)   
  APACHE II score After 24 hours in ICU   
  
Duration of mechanical 
ventilation(MV) 
Time (days)   
  Complications of MV VAP   
  Pneumothorax   
  Difficult wean   
    Prolonged wean   
    Failed extubation   
  Duration of ICU stay Time (days)   
  Duration of Medical High Care     
  Duration of Hospital stay (Days) Time (days)   
  Tracheostomised Y/N   
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Addendum 2 : Charlson Co-morbidity score 
 
 
Condition Assigned Weight Condition Assigned Weight 
myocardial infarction 1 Hemiplegia 2 
congestive heart failure 1 renal disease moderate or 
severe 
2 
peripheral vascular disease 1 diabetes with end organ 
damage 
2 
cerebrovascular disease 1 any malignancy 2 
Dementia 1 Leukemia 2 
chronic pulmonary disease 1 malignant lymphoma 2 
connective tissue disease 1 liver disease. moderate or 
severe 
3 
ulcer disease 1 metastatic solid malignancy 6 
liver disease mild 1 AIDS 6 
Diabetes 1   
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Glossary 
 
• Refractory Acidosis: pH persistently less than 7.3 despite optimal resuscitation  
• Accessory Muscles: suprasternal, intercostal and abdominal muscles 
• Chest X-Ray features: 
o Hyperinflation- Appearance on Chest radiograph of an increased lung 
volume suggested by more than 6 anterior ribs on the PA view. 
o Pulmonary infiltrates- the appearance of abnormal shadowing on the 
chest radiograph. These may be areas of opacification, reticulation or 
micro-nodules. 
o Structural lung disease- The presence of irreversible fibrotic changes 
on a chest radiograph which may be associated with volume loss.  
 
• Complications of ventilation: 
o Ventilator associated pneumonia- nosocomial bacterial pneumonia 
                        that has developed in patients who are receiving mechanical ventilation 
o Prolonged- Patients who fail initial weaning and require up to three 
Spontaneous Breathing Trials(SBT) or as long as 7 days from the first 
SBT to achieve successful weaning 
o Prolonged mechanical ventilation- receiving continuous mechanical 
ventilation for 7 days or longer 
o Failed extubation- Patient having to be re-intubated or dying within 
72 hours of extubation 
• APACHE II – Acute Physiology and Chronic Health evaluation II. – A 
prognostic scoring system used in the ICU 
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• Number of Pack Years - (number of cigarettes smoked per day x number of 
years smoked)/20 
• Functional Grade 
    -   Grade 1- independent  
         -   Grade 2- Restricted but leaves House  
         -   Grade 3- Housebound but ambulant and able to perform self care 
         -   Grade 4- Bed/chair bound, unable to perform self-care 
• FEV1 : Forced Expiratory Volume in 1 second 
• FVC - Forced Vital capacity 
• ECG diagnosis of ischaemic heart disease 
      Signs of Myocardial infarction according to the Minnesota codex: 
                   -  ST elevation or depression of at least 1.5mm 
                 -  negative T-wave in the absence of pharmacological and extra cardiac     
                     conditions known to affect repolarization   
• Cor Pulmonale  
o Clinical - Palpation of left parasternal heave with auscultatory features of a 
loud second heart sound in the pulmonary area 
o ECG - signs of right ventricular hypertrophy (RVH) or overload 
§ Type A RVH : dominant R wave in V1 and V2, rS pattern in V5 
and V6 
§ Type B RVH : Rs pattern in V1, absent or marginal increase of R 
wave amplitude 
§ Type C RVH : absent or marginal increase of R wave amplitude 
from V1-V6, deep S-wave in all praecordial leads 
• Type 1 Respiratory Failure  :  PaO2 < 8 kPa ; PaCO2  < 7 kPA 
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• Type 2 Respiratory Failure  :  PaO2 < 8 kPa ; PaCO2  > 7 kPA 
• ALT : Aminoalaninetransferase 
• CRP : C-Reactive Protein 
• Cr = Creatinine 
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